Abstract
Molecular classification of diffuse large B-cell lymphoma (DLBCL) is a critical biologic, prognostic, and predictive distinction. Since the discovery of two molecular types of DLBCL in otherwise morphologically indistinguishable cases, numerous methodologies for making this distinction have been published. A method and technical platform may now be reaching consensus.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2204-2206 |
| Number of pages | 3 |
| Journal | Clinical Cancer Research |
| Volume | 21 |
| Issue number | 10 |
| DOIs | |
| State | Published - May 15 2015 |
ASJC Scopus subject areas
- General Medicine